Home >> Blog >> Paragon Fine & Speciality Chemicals IPO-Review, Opening Date
Paragon Fine & Speciality Chemicals IPO-Review, Opening Date
Table of Contents
- Paragon Fine And Speciality Chemicals Limited - Complete Overview
- What does the company do?
- IPO Overview
- Company Financial
- Objective of the Issue
- Promoters and Management of Paragon Fine And Speciality Chemicals Limited
- Peer Comparison
- IPO's Valuations
- Dividend Policy
- IPO's Strengths
- IPO Weaknesses
- IPO GMP Today
- Conclusion
Paragon Fine And Speciality Chemicals Limited - Complete Overview
Founded in 2004, Paragon Fine And Speciality Chemicals Limited is actively involved in the custom synthesis and production of specialized chemical intermediates that demand intricate and distinctive chemistry.
The company initially began its journey as a partnership firm in 2004 and has since transformed into a leader in the custom synthesis and manufacturing of a wide spectrum of products, including Pharma Intermediates, AGRO Intermediates, Cosmetics Intermediates, Pigment Intermediates, and Dye Intermediates, catering to a diverse clientele both in India and globally.
The company's manufacturing facility, strategically located in the Viramgam District of Ahmedabad, Gujarat, spans approximately 7000 square meters and is equipped with a variety of reactors that enable the production of a wide array of chemical compounds. Additionally, the company boasts a pilot plant featuring two glass line assemblies and three reactors, dedicated to batch reaction technology.
Paragon Fine And Speciality Chemicals Limited takes pride in its in-house R&D facility, complete with well-equipped laboratories that engage in the development and innovation of catalytic processes and new chemical screening. This robust R&D capability empowers the company to optimize and streamline product development from the initial conceptualization through to commercialization.
The company's R&D team has accomplished the successful execution of multi-step synthesis and scale-up for numerous novel molecules in the realm of speciality intermediates. As a result, the company has significantly expanded its portfolio from approximately 100 products in Fiscal Year 2021 to around 140 by Fiscal Year 2023. As of March 31, 2023, the company's R&D team comprises 14 highly skilled technocrats.
What does the company do?
Paragon Fine And Speciality Chemicals Limited specialize in custom synthesis and the production of speciality chemical intermediates, which require intricate and distinct chemistry.
IPO Overview
The Paragon Fine And Speciality Chemicals Limited IPO date is scheduled to open from October 26, 2023, to October 30, 2023. This SME IPO falls under the category of a Book Built Issue IPO.
The total issue size for this upcoming SME IPO amounts to ?51.66 Crores. From this total issue size, the company has allocated 50% for institutional investors, 15% for non-institutional investors, and 35% for retail investors.
The Paragon Fine And Speciality Chemicals Limited IPO price has been set within the range of ?95 to ?100 per share. Each lot of shares consists of 1200 shares.
Continue reading for a more comprehensive and detailed IPO review.
Paragon Fine And Speciality Chemicals Limited IPO timetable (Tentative)
Events |
Date |
IPO Opening Date |
26 October 2023 |
IPO Closing Date |
30 October 2023 |
IPO Allotment Date |
2 November 2023 |
Refund initiation |
3 November 2023 |
IPO Listing Date |
7 November 2023 |
Paragon Fine And Speciality Chemicals Limited IPO Details
IPO opening & closing date |
26 October to 30 October 2023 |
Face value |
Rs. 10 per Share |
Issue Price |
Rs. 95 to Rs.100 per Share |
Lot Size |
1200 Shares |
Price of 1 lot |
Rs. 120,000 |
Issue Size |
5,166,000 Shares (aggregating up to Rs. 51.66 Cr) |
Offer for sale |
NA |
Fresh issue |
5,166,000 Shares (aggregating up to Rs. 51.66 Cr) |
Listing at |
NSE SME |
Issue Type |
Book Built Issue IPO |
Registrar |
Bigshare Services Pvt. Ltd. |
Paragon Fine And Speciality Chemicals Limited IPO Lot Details
Minimum Lot Investment (Retail) |
1 Lot |
Maximum Lot Investment (Retail) |
1 Lot |
Minimum Lot Investment (HNI) |
2 Lot |
Paragon Fine And Speciality Chemicals Limited IPO Reservation
Institutional Share Portion |
50% |
Non-institutional Share Portion |
15% |
Retail Share Portion |
35% |
Company Financial
Amount in Lakhs
Period |
31 Mar 2023 |
31 Mar 2022 |
31 Mar 2021 |
Total Assets |
7,097.84 |
5,750.53 |
4,983.26 |
Total Revenue |
10,501.19 |
8,457.92 |
8,436.94 |
PAT |
989.21 |
449.02 |
439.77 |
Net worth |
2,233.52 |
1,244.31 |
795.29 |
Reserve & Surplus |
1,873.52 |
1,234.31 |
785.29 |
Total Borrowings |
2,521.03 |
2,068.16 |
2,193.00 |
Geography-wise Revenue Bifurcation
(Amount in Lakhs)
Particulars |
Fiscal 2023 |
Fiscal 2022 |
Fiscal 2021 |
India |
6762.60 |
3812.20 |
3111.73 |
Outside India |
|||
1. Asia |
2776.49 |
3404.55 |
4874.50 |
2. Europe |
319.68 |
408.51 |
218.97 |
3. North America |
367.85 |
657.68 |
120.35 |
Total |
10226.62 |
8282.94 |
8325.55 |
Product-wise Revenue Bifurcation
(Amount in Lakhs)
Product Category |
Fiscal 2023 |
Fiscal 2022 |
Fiscal 2021 |
Agro intermediates |
915.64 |
1,478.56 |
360.95 |
Cosmetics Intermediates |
630.07 |
590.15 |
575.32 |
Dyes intermediates |
7,044.37 |
5,187.98 |
6,565.87 |
Pharma intermediates |
6.66 |
6.31 |
4.84 |
Pigment Intermediates |
108.39 |
- |
27.32 |
Specialty Intermediates |
1,460.57 |
996.03 |
664.63 |
Others |
60.92 |
23.91 |
126.62 |
Total |
10,226.62 |
8,282.94 |
8,325.55 |
Objective of the Issue
The net proceeds from this IPO will serve the following objectives:
- Supporting capital expenditure for civil construction within the current factory premises.
- Either fully or partially repaying certain outstanding borrowings.
- Financing capital expenditure for the installation of additional plant and machinery to facilitate expansion.
- Meeting working capital needs.
- Addressing general corporate requirements.
Promoters and Management of Paragon Fine And Speciality Chemicals Limited
Dr. Pravinchandra Jasmat Vasolia, Kishorkumar Panchabhai Patolia, Vallabh Ratanji Savaliya, Rutesh Vallabhbhai Savalia, and Shivam Kishorbhai Patolia are the promoters of the company.
Pre-issue Promoter Shareholding |
100.00% |
Post-issue Promoter Shareholding |
73.60% |
Peer Comparison
Below are the listed peers of Paragon Fine And Speciality Chemical Limited
Below are the listed peers of Paragon Fine And Speciality Chemical Limited
Company Name |
EPS |
P/E |
Total Income (Rs. In Crores) |
Paragon Fine And Speciality Chemical Limited |
6.87 |
- |
105.01 |
Aether Industries Limited |
10.47 |
100.04 |
667.64 |
Anupam Rasayan India Ltd |
20.91 |
48.41 |
1610.47 |
Bodal Chemicals Ltd |
3.03 |
24.16 |
1585.89 |
Deepak Nitrite Ltd |
62.47 |
31.94 |
8019.64 |
IPO's Valuations
With an IPO price range of Rs. 95 to Rs. 100 per share and an EPS of Rs. 6.87, the company's P/E ratio to assess the IPO valuation, calculated based on the upper end of the issue price, amounts to 14.55.
Dividend Policy
According to the Paragon Fine And Speciality Chemicals Limited IPO DRHP, the company has not distributed dividends in previous years, and any potential future dividend payments will be contingent upon the company's future performance.
IPO's Strengths
- Diverse product portfolio with customization capabilities.
- Emphasis on research and development for harnessing intricate chemistry and technology.
- Established and enduring customer relationships spanning various regions.
- In-house manufacturing facility equipped with advanced technologies and processes.
- Commitment to quality, environmental responsibility, health, and safety.
- Demonstrated financial strength and stability.
- Seasoned Promoters and Senior Management possessing extensive domain expertise.
IPO Weaknesses
- The company derives a significant portion of its revenue from key customers, and it lacks long-term contracts with many of these clients.
- Relying heavily on specific industries for a significant share of its sales could potentially have adverse implications for the company's business.
- A substantial portion of the company's revenue comes from exports, making it susceptible to international trade risks.
- The company is subject to rigorous quality standards, regular inspections, and audits.
- Stringent environmental, health, and safety laws, regulations, and standards increasingly impact the company.
- Discrepancies and errors have been identified in certain corporate records of the company, specifically related to forms filed with the Registrar of Companies and other provisions of the Companies Act.
- The company faces competition from both domestic and multinational corporations in its industry.
- The company is currently involved in legal proceedings and potential litigations.
- Certain entities within the Promoter Group are engaged in a similar line of business as the company.
IPO GMP Today
The Latest GMP of Paragon Fine And Speciality Chemicals SME IPO is Rs. 55.
Conclusion
The company operates within a fiercely competitive industry, boasting an extensive product portfolio and a robust customer base. However, the notable surge in the company's profits during FY 23 might be viewed as a potential embellishment in preparation for the IPO. Seasoned investors are likely to scrutinize all relevant factors before considering an investment in this offering.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.
Frequently Asked Questions
This is a subjective question, and the answer will depend on your individual investment goals and risk tolerance. However, here are some factors to consider:
- The company has a diverse product portfolio and a robust customer base.
- The company has demonstrated financial strength and stability.
- The company is led by a seasoned management team with extensive domain expertise.
- However, the company operates in a fiercely competitive industry.
- The company's recent surge in profits might be a red flag for some investors.
Overall, the Paragon Fine And Speciality Chemicals Limited IPO is a mixed bag. Investors should carefully consider all the risks before investing in this offering.
The key strengths of Paragon Fine And Speciality Chemicals Limited include:
- Diverse product portfolio with customization capabilities
- Emphasis on research and development for harnessing intricate chemistry and technology
- Established and enduring customer relationships spanning various regions
- In-house manufacturing facility equipped with advanced technologies and processes
- Commitment to quality, environmental responsibility, health, and safety
- Demonstrated financial strength and stability
- Seasoned Promoters and Senior Management possessing extensive domain expertise
The key weaknesses of Paragon Fine And Speciality Chemicals Limited include:
- The company derives a significant portion of its revenue from key customers, and it lacks long-term contracts with many of these clients.
- Relying heavily on specific industries for a significant share of its sales could potentially have adverse implications for the company's business.
- A substantial portion of the company's revenue comes from exports, making it susceptible to international trade risks.
- The company is subject to rigorous quality standards, regular inspections, and audits.
- Stringent environmental, health, and safety laws, regulations, and standards increasingly impact the company.
- Discrepancies and errors have been identified in certain corporate records of the company, specifically related to forms filed with the Registrar of Companies and other provisions of the Companies Act.
- The company faces competition from both domestic and multinational corporations in its industry.
- The company is currently involved in legal proceedings and potential litigations.
- Certain entities within the Promoter Group are engaged in a similar line of business as the company.
The Latest GMP of Paragon Fine And Speciality Chemicals SME IPO is Rs. 55.
Some of the risks associated with investing in Paragon Fine And Speciality Chemicals Limited IPO include:
- The company operates in a fiercely competitive industry.
- The company's recent surge in profits might be a red flag for some investors.
- The company is exposed to international trade risks.
- The company is subject to stringent regulatory requirements.
- The company is involved in legal proceedings and potential litigations.
Investors should carefully consider all the risks before investing in this offering.